These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 18196519

  • 1. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse.
    Huang CY, Bredemeyer AL, Walker LM, Bassing CH, Sleckman BP.
    Eur J Immunol; 2008 Feb; 38(2):342-9. PubMed ID: 18196519
    [Abstract] [Full Text] [Related]

  • 2. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J, Morello D.
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [Abstract] [Full Text] [Related]

  • 3. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J, Knauer R, Schimpl A, Wecker E.
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [Abstract] [Full Text] [Related]

  • 4. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation.
    Gregory MA, Xiao Q, Cornwall GA, Lutterbach B, Hann SR.
    Oncogene; 2000 Oct 05; 19(42):4886-95. PubMed ID: 11039906
    [Abstract] [Full Text] [Related]

  • 5. By-stander activation in autoimmune thyroiditis: studies on experimental autoimmune thyroiditis in the GFP+ fluorescent mouse.
    Arata N, Ando T, Unger P, Davies TF.
    Clin Immunol; 2006 Oct 05; 121(1):108-17. PubMed ID: 16916620
    [Abstract] [Full Text] [Related]

  • 6. Expression of a rlf/L-myc minigene inhibits differentiation of embryonic stem cells and embroid body formation.
    MacLean-Hunter S, Mäkelä TP, Grzeschiczek A, Alitalo K, Möröy T.
    Oncogene; 1994 Dec 05; 9(12):3509-17. PubMed ID: 7970711
    [Abstract] [Full Text] [Related]

  • 7. Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death.
    Arnaud-Dabernat S, Masse K, Smani M, Peuchant E, Landry M, Bourbon PM, Le Floch R, Daniel JY, Larou M.
    Exp Cell Res; 2004 Dec 10; 301(2):293-304. PubMed ID: 15530864
    [Abstract] [Full Text] [Related]

  • 8. Novel reporter cell line to analyze cytokine-mediated expression regulation of c-myc gene.
    Fujii H.
    J Biosci Bioeng; 2009 Nov 10; 108(5):438-40. PubMed ID: 19804871
    [Abstract] [Full Text] [Related]

  • 9. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.
    Mycko MP, Ferrero I, Wilson A, Jiang W, Bianchi T, Trumpp A, MacDonald HR.
    J Immunol; 2009 Apr 15; 182(8):4641-8. PubMed ID: 19342639
    [Abstract] [Full Text] [Related]

  • 10. Defining the specific physiological requirements for c-Myc in T cell development.
    Douglas NC, Jacobs H, Bothwell AL, Hayday AC.
    Nat Immunol; 2001 Apr 15; 2(4):307-15. PubMed ID: 11276201
    [Abstract] [Full Text] [Related]

  • 11. Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster.
    Benassayag C, Montero L, Colombié N, Gallant P, Cribbs D, Morello D.
    Mol Cell Biol; 2005 Nov 15; 25(22):9897-909. PubMed ID: 16260605
    [Abstract] [Full Text] [Related]

  • 12. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP, de Bruijn MJ, Dingjan GM, Beverloo HB, Diepstraten H, Ling KW, Hendriks RW.
    Mol Immunol; 2008 Jun 15; 45(11):3085-95. PubMed ID: 18471881
    [Abstract] [Full Text] [Related]

  • 13. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
    Nilsson LM, Keller UB, Yang C, Nilsson JA, Cleveland JL, Roussel MF.
    Oncogene; 2007 May 03; 26(20):2833-9. PubMed ID: 17099725
    [Abstract] [Full Text] [Related]

  • 14. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
    Bello Roufai M, Li H, Sun Z.
    Gene Ther; 2007 Oct 03; 14(19):1406-16. PubMed ID: 17637797
    [Abstract] [Full Text] [Related]

  • 15. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.
    Pascal SM, Guiot Y, Pelengaris S, Khan M, Jonas JC.
    Am J Physiol Endocrinol Metab; 2008 Jul 03; 295(1):E92-102. PubMed ID: 18413670
    [Abstract] [Full Text] [Related]

  • 16. Healthy mice with an altered c-myc gene: role of the 3' untranslated region revisited.
    Langa F, Lafon I, Vandormael-Pournin S, Vidaud M, Babinet C, Morello D.
    Oncogene; 2001 Jul 19; 20(32):4344-53. PubMed ID: 11466615
    [Abstract] [Full Text] [Related]

  • 17. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM, Zaheen A, Basit W, Li L, Berger SA, Martin A.
    Oncogene; 2008 Aug 07; 27(34):4752-6. PubMed ID: 18408759
    [Abstract] [Full Text] [Related]

  • 18. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP, Fernández-García B, García-Sanz P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marín MC, León J.
    Mol Cancer Res; 2008 Feb 07; 6(2):325-39. PubMed ID: 18314492
    [Abstract] [Full Text] [Related]

  • 19. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death.
    de Alborán IM, Baena E, Martinez-A C.
    Cell Death Differ; 2004 Jan 07; 11(1):61-8. PubMed ID: 12970677
    [Abstract] [Full Text] [Related]

  • 20. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness.
    Liou LB, Wu MW, Chao WJ.
    Scand J Immunol; 2009 May 07; 69(5):447-56. PubMed ID: 19508376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.